Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alliqua Biomedical Inc    ALQA

ALLIQUA BIOMEDICAL INC (ALQA)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 19,4 M
EBIT 2017 -16,1 M
Net income 2017 -17,8 M
Debt 2017 -
Yield 2017 -
Sales 2018 22,5 M
EBIT 2018 -10,8 M
Net income 2018 -14,5 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0,84x
Capi. / Sales2018 0,72x
Capitalization 16,2 M
More Financials
Company
Alliqua BioMedical, Inc. is a regenerative technologies company, which commercializes differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue.The firm builds a suite of technological solutions that allow clinicians to utilize the latest... 
More about the company
Surperformance© ratings of Alliqua Biomedical Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ALLIQUA BIOMEDICAL INC
10/06 ALLIQUA BIOMEDICAL : Announces 1-for-10 Reverse Stock Split
10/05 ALLIQUA BIOMEDICAL, INC. (NASDAQ : ALQA) Files An 8-K Amendments to Articles of ..
10/05 ALLIQUA BIOMEDICAL, INC. : Amendments to Articles of Inc. or Bylaws; Change in F..
10/05 Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split
09/14 ALLIQUA BIOMEDICAL, INC. (NASDAQ : ALQA) Files An 8-K Submission of Matters to a..
09/13 ALLIQUA BIOMEDICAL, INC. : Submission of Matters to a Vote of Security Holders (..
09/05 ALLIQUA BIOMEDICAL, INC. : Entry into a Material Definitive Agreement, Other Eve..
09/05 ALLIQUA BIOMEDICAL : Announces the Sale of TheraBond® 3D Antimicrobial Barrier S..
09/01 ALLIQUA BIOMEDICAL, INC. : Change in Directors or Principal Officers, Financial ..
08/10 ALLIQUA BIOMEDICAL, INC. (NASDAQ : ALQA) reported earnings of ($0.09) per share ..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/23DJLUXOTTICA : 3Q Sales Fall; Backs Guidance for 2017
10/23 Smith & Nephew to buy Rotation Medical for up to $210 million
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
10/10ValuEngine Upgrades Alliqua BioMedical, Inc. $ALQA to Hold  
10/07Alliqua BioMedical upgraded by ValuEngine to hold.  
10/06$ALQA buyers are back..... could see a nice move now and fill the gap. 
10/06$ALQA adding slowly sub $3 The float is tiny now, big problem for shorts. Plu.. 
10/06Alliqua Bio's 1:10 reverse split effective today; shares off 10%  
More tweets
Qtime:94
News from SeekingAlpha
10/06 Midday Gainers / Losers
10/06 HEALTHCARE - TOP 5 GAINERS / LOSERS : 15 pm
10/06 ALLIQUA BIO'S 1 : 10 reverse split effective today; shares off 10%
08/28 FDA clears Alliqua BioMedical's SilverSeal wound dressing; shares up 32%
08/10 Alliqua BioMedical's (ALQA) CEO Dave Johnson on Q2 2017 Results - Earnings Ca..
Chart ALLIQUA BIOMEDICAL INC
Duration : Period :
Alliqua Biomedical Inc Technical Analysis Chart | ALQA | US0196212007 | 4-Traders
Technical analysis trends ALLIQUA BIOMEDICAL INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 11,3 $
Spread / Average Target 248%
EPS Revisions
Managers
NameTitle
David Ian Johnson President, Chief Executive Officer & Director
Jerome B. Zeldis Chairman
Bradford C. Barton Chief Operating Officer
Brian M. Posner Chief Financial Officer, Secretary & Treasurer
Joseph M. Leone Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALLIQUA BIOMEDICAL INC-52.37%16
MEDTRONIC PLC9.98%106 119
BAXTER INTERNATIONAL43.41%34 648
ZIMMER BIOMET HOLDINGS INC18.56%24 739
C R BARD INC46.96%23 993
HOYA CORPORATION29.77%21 802